Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LiquidLung-A: Afatinib in EGFR-mutated NSCLC via ctDNA
NCT02629523Phase 2Completed
- Sponsor
- Chonnam National University Hospital
- Start
- Jun 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of afatinib in non-small cell lung cancer (NSCLC), sponsored by Chonnam National University Hospital. Started Jun 2016; status: completed.
02
Drugs
afatinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02629523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02629523.